Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

8th Joint ACTRIMS-ECTRIMS (MSVirtual2020) Meeting to Be Held Virtually September 11-13, 2020 with an Encore Event on September 26th with Late Breakers and Special Session on COVID-19

~ MSVirtual2020 To Feature the Latest Clinical Advances, Major Data Announcements, and Scientific Breakthroughs in Multiple Sclerosis and Demyelinating Diseases~ ~Media Offered Access to Full Program, Plenary Sessions, Platform Presentations and Invited to Participate in Special Press Events~

Newswise — “Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both scheduled and on-demand.”

Given the worldwide impact of COVID-19 and taking into consideration the health and safety of attendees, including the media, the 8th Joint ACTRIMS-ECTRIMS Meeting will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26. 

We invite media from around the world to join us for this virtual conference that involves world class scientists, clinicians and researchers in the multiple sclerosis (MS) field who will be sharing the latest research advances, clinical trial data, and new cutting-edge technology in MS. 

Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both scheduled and on-demand. Poster presentations will be available upon registration and by signing into the virtual meeting. Press events will be held to provide media with the opportunity to speak with and ask questions directly to ACTRIMS/ECTRIMS leaders, key clinicians and study investigators regarding scientific advances, clinical trial outcomes, late-breakers, and emerging trends in the MS field.  Special press events currently planned will include: 

  • Opening Press Conference with ACTRIMS and ECTRIMS Leaders 
    • Friday, September 11th @8:00 a.m. ET
  • Virtual Coffee Breaks with the President 
    • Sunday, September 13th @ 10:30 a.m. ET
  • Late Breaker Abstracts Available under Embargo (by request)
    • Thursday, September 24th 
  • Embargoed Late-Breaker Press Event – Q&A with Investigators (exclusive to media)
    • Friday, September 25th @ 9:00 a.m.ET
  • Encore Event:  Late Breaker Presentations (for all attendees and media)
    • Saturday, September 26th at 9-10:30 
  • Encore Event:  Covid-19 and MS Special Session (for all attendees and media)
    • Saturday, September 26th @ 10:45-12:15 

Press managers are available anytime to register you, provide conference information, and facilitate interviews with ACTRIMS/ECTRIMS leaders, clinicians, researchers and investigators. 

Press Credentials: Media can register for the MSVirtual2020 free-of-charge by completing the registration online, or by emailing the press managers your media credentials (i.e., signature contact including media outlet, or letterhead, or letter for editor or producer. Bloggers will need to provide recent samples of posts.  Freelancers can send a note from an Editor requesting they cover the conference, or by providing recent copies of published articles. For more details on press credentials, please go here. 

Embargoed Dates: The attending media must adhere to the embargoed dates. Abstracts and featured research accepted for presentation at MSVirtual2020 are embargoed until they are in the online meeting library. Full text of regular abstracts will be published September 1. Full text of Late-Breaking Abstracts will be published on September 25. 

 




Filters close

Showing results

110 of 2836
access_time Embargo lifts in 2 days
Embargo will expire: 10-Aug-2020 8:00 AM EDT Released to reporters: 7-Aug-2020 7:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Aug-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-Aug-2020 2:25 PM EDT
Alcoholism treatment is potentially effective against COVID-19
National Research University - Higher School of Economics (HSE)

A team of chemists from HSE University and the Zelinsky Institute of Organic Chemistry used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2.

Newswise: 239651_web.jpg
Released: 7-Aug-2020 1:10 PM EDT
Electric cooker an easy, efficient way to sanitize N95 masks, study finds
University of Illinois at Urbana-Champaign

Owners of electric multicookers may be able to add another use to its list of functions, a new study suggests: sanitization of N95 respirator masks.

Released: 7-Aug-2020 12:05 PM EDT
Study: Most Americans don't have enough assets to withstand 3 months without income
Oregon State University

A new study from Oregon State University found that 77% of low- to moderate-income American households fall below the asset poverty threshold, meaning that if their income were cut off they would not have the financial assets to maintain at least poverty-level status for three months.

Released: 7-Aug-2020 11:55 AM EDT
COVID recovery choices shape future climate
University of Leeds

A post-lockdown economic recovery plan that incorporates and emphasises climate-friendly choices could help significantly in the battle against global warming, according to a new study.

access_time Embargo lifts in 2 days
Embargo will expire: 11-Aug-2020 11:00 AM EDT Released to reporters: 7-Aug-2020 10:55 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-Aug-2020 9:45 AM EDT
Potentially predictive humoral immune response markers in COVID-19 patients
Massachusetts General Hospital

Galit Alter, PhD, Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and Helen Chu, MD, Associate Professor of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, and UW Medicine physician, have recently published a paper which identifies five immune response markers which, collectively, were able to correctly classify both convalescent COVID-19 patients and those who did not survive the disease

Released: 7-Aug-2020 9:00 AM EDT
ACSM Publishes Call to Action Addressing COVID-19 and Return to Sports and Physical Activity
American College of Sports Medicine (ACSM)

ACSM published a call to action statement addressing COVID-19 and safely returning to sports and exercise. Authored by ACSM subject matter experts, the statement highlights the current science around COVID-19 and provides 12 action steps to consider. “COVID-19: Considerations for Sports and Physical Activity” is ACSM’s first call to action statement and published in the August issue of Current Sports Medicine Reports.

Newswise: University of Miami Sports Medicine Institute expert leads call to action for harnessing exercise’s health benefits during the pandemic
7-Aug-2020 9:00 AM EDT
University of Miami Sports Medicine Institute expert leads call to action for harnessing exercise’s health benefits during the pandemic
University of Miami Health System, Miller School of Medicine

To address and overcome the challenges so Americans can return to or sustain physical activity safely, Thomas M. Best, M.D., Ph.D., FACSM, professor of orthopedic surgery at the University of Miami Miller School of Medicine and research director of the UHealth Sports Medicine Institute, and sports medicine colleagues from around the U.S. wrote “COVID-19: Considerations for Sports and Physical Activity,” published August 7 in Current Sports Medicine Reports, an American College of Sports Medicine journal.


Showing results

110 of 2836

close
1.76764